CLINICAL_TRIALS
trial_result
· 2016-03-11
Clinical Trial Update: Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer [Phase 2]
Summary
This Phase 2 trial evaluated adding adjuvant intraperitoneal floxuridine to chemoradiation after complete resection in advanced gastric cancer; the study has co…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Gastric Cancer, Stomach Cancer | Phase 2 | Status: COMPLETED